179 related articles for article (PubMed ID: 2144431)
21. Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.
Birmingham DJ; Gavit KF; McCarty SM; Yu CY; Rovin BH; Nagaraja HN; Hebert LA
Clin Exp Immunol; 2006 Feb; 143(2):274-80. PubMed ID: 16412051
[TBL] [Abstract][Full Text] [Related]
22. The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Hirose S; Miyamoto T
Clin Exp Immunol; 1985 Jun; 60(3):613-21. PubMed ID: 3160514
[TBL] [Abstract][Full Text] [Related]
23. Quantification by ELISA of erythrocyte-bound C3 fragments expressing C3d and/or C3c epitopes in patients with factor I deficiency and with autoimmune diseases.
Møller Rasmussen J; Jepsen HH; Teisner B; Holmskov-Nielsen U; Rasmussen GG; Svehag SE
Vox Sang; 1989; 56(4):262-9. PubMed ID: 2474900
[TBL] [Abstract][Full Text] [Related]
24. Erythrocyte CR1 determination using monoclonal antibody in a microtiter plate ELISA; receptors are not masked by immune complexes.
Thomsen BS; Nielsen H; Bendixen G
Allergy; 1986 Sep; 41(7):479-86. PubMed ID: 2947511
[TBL] [Abstract][Full Text] [Related]
25. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.
Mitchell JA; Batchelor JR; Chapel H; Spiers CN; Sim E
Clin Exp Immunol; 1987 May; 68(2):446-56. PubMed ID: 2958187
[TBL] [Abstract][Full Text] [Related]
26. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
[TBL] [Abstract][Full Text] [Related]
27. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
[TBL] [Abstract][Full Text] [Related]
28. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.
Henderson AL; Lindorfer MA; Kennedy AD; Foley PL; Taylor RP
J Immunol Methods; 2002 Dec; 270(2):183-97. PubMed ID: 12379324
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritis.
Jouvin MH; Wilson JG; Bourgeois P; Fearon DT; Kazatchkine MD
Complement; 1986; 3(2):88-96. PubMed ID: 2945697
[TBL] [Abstract][Full Text] [Related]
30. A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).
Ng YC; Peters DK; Cederholm-Williams SA; Walport MJ
Clin Exp Immunol; 1987 Jul; 69(1):89-97. PubMed ID: 3115654
[TBL] [Abstract][Full Text] [Related]
31. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
Taylor RP; Pocanic F; Reist C; Wright EL
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
[TBL] [Abstract][Full Text] [Related]
32. [Erythrocyte CR1 receptor reactivity in patients with systemic lupus erythematosus].
Said PB; Sarano J; Manni JA; Casellas AM
Medicina (B Aires); 1990; 50(1):21-4. PubMed ID: 2149869
[TBL] [Abstract][Full Text] [Related]
33. A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.
Birmingham DJ; Chen W; Liang G; Schmitt HC; Gavit K; Nagaraja HN
Immunology; 2003 Apr; 108(4):531-8. PubMed ID: 12667215
[TBL] [Abstract][Full Text] [Related]
34. Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface.
Walport M; Ng YC; Lachmann PJ
Clin Exp Immunol; 1987 Sep; 69(3):501-7. PubMed ID: 2959411
[TBL] [Abstract][Full Text] [Related]
35. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.
Walport MJ; Ross GD; Mackworth-Young C; Watson JV; Hogg N; Lachmann PJ
Clin Exp Immunol; 1985 Mar; 59(3):547-54. PubMed ID: 3987091
[TBL] [Abstract][Full Text] [Related]
36. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
[TBL] [Abstract][Full Text] [Related]
37. Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjögren's syndrome.
Thomsen BS; Oxholm P; Manthorpe R; Nielsen H
Arthritis Rheum; 1986 Jul; 29(7):857-62. PubMed ID: 2943291
[TBL] [Abstract][Full Text] [Related]
38. CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism.
Mitchell JA; Sim RB; Sim E
Clin Exp Immunol; 1989 Dec; 78(3):354-8. PubMed ID: 2575471
[TBL] [Abstract][Full Text] [Related]
39. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
Paccaud JP; Carpentier JL; Schifferli JA
Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
[TBL] [Abstract][Full Text] [Related]
40. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
